Technical Analysis for IMTX - Immatics N.V.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 10.20 | -2.11% | -0.22 |
IMTX closed up 2.26 percent on Tuesday, April 23, 2024, on 87 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 14
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Oversold Stochastic | Weakness | -2.11% | |
Oversold Stochastic | Weakness | 0.10% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -0.10% | |
Inside Day | Range Contraction | -0.10% | |
Oversold Stochastic | Weakness | -0.10% | |
Doji - Bullish? | Reversal | -0.58% | |
Outside Day | Range Expansion | -0.58% | |
Lower Bollinger Band Touch | Weakness | -0.58% | |
Oversold Stochastic | Weakness | -0.58% | |
180 Bearish Setup | Bearish Swing Setup | -0.29% |
Alert | Time |
---|---|
Down 2 % | about 3 hours ago |
Fell Below Previous Day's Low | about 4 hours ago |
60 Minute Opening Range Breakdown | about 4 hours ago |
10 DMA Resistance | about 4 hours ago |
10 DMA Support | about 5 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/14/2024
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its clinical pipelines include adoptive cell therapy (ACT) and TCR biscpecifics (TCER™). Its therapeutic approaches are ACTengine, Next Generation ACT, and TCER. The company was founded on March 10, 2020 and is headquartered in Tuebingen, Germany.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Cancer Clinical Medicine Immune System Immunotherapy Cancer Treatment Treatment Of Cancer Cell Therapy Virotherapy Immunotherapies T Cell Adoptive Cell Transfer
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Cancer Clinical Medicine Immune System Immunotherapy Cancer Treatment Treatment Of Cancer Cell Therapy Virotherapy Immunotherapies T Cell Adoptive Cell Transfer
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 13.16 |
52 Week Low | 6.46 |
Average Volume | 440,507 |
200-Day Moving Average | 10.88 |
50-Day Moving Average | 11.43 |
20-Day Moving Average | 10.65 |
10-Day Moving Average | 10.45 |
Average True Range | 0.50 |
RSI (14) | 40.83 |
ADX | 24.73 |
+DI | 12.55 |
-DI | 16.93 |
Chandelier Exit (Long, 3 ATRs) | 10.20 |
Chandelier Exit (Short, 3 ATRs) | 11.53 |
Upper Bollinger Bands | 11.30 |
Lower Bollinger Band | 9.99 |
Percent B (%b) | 0.33 |
BandWidth | 12.38 |
MACD Line | -0.33 |
MACD Signal Line | -0.32 |
MACD Histogram | -0.0099 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 10.95 | ||||
Resistance 3 (R3) | 10.95 | 10.77 | 10.86 | ||
Resistance 2 (R2) | 10.77 | 10.64 | 10.77 | 10.83 | |
Resistance 1 (R1) | 10.60 | 10.56 | 10.69 | 10.60 | 10.80 |
Pivot Point | 10.42 | 10.42 | 10.47 | 10.42 | 10.42 |
Support 1 (S1) | 10.25 | 10.29 | 10.34 | 10.25 | 10.04 |
Support 2 (S2) | 10.07 | 10.21 | 10.07 | 10.01 | |
Support 3 (S3) | 9.90 | 10.07 | 9.98 | ||
Support 4 (S4) | 9.90 |